ANGELALIGN TECHNOLOGY INC. Angelalign Technology Inc. Stock
Equities
6699
KYG0405D1051
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.9 HKD | +5.13% |
|
+8.56% | +41.29% |
| Sales 2024 * | 1.73B 239M 1.87B | Sales 2025 * | 2.13B 293M 2.3B | Capitalization | 11.9B 1.64B 12.86B |
|---|---|---|---|---|---|
| Net income 2024 * | 72M 9.94M 77.81M | Net income 2025 * | 165M 22.78M 178M | EV / Sales 2024 * | 5.29 x |
| Net cash position 2024 * | 2.72B 376M 2.94B | Net cash position 2025 * | 3.23B 446M 3.49B | EV / Sales 2025 * | 4.08 x |
| P/E ratio 2024 * |
160
x | P/E ratio 2025 * |
70.4
x | Employees | 2,883 |
| Yield 2024 * |
1.12% | Yield 2025 * |
1.29% | Free-Float | 21.26% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | +5.13% | ||
| 1 week | +8.56% | ||
| Current month | +6.25% | ||
| 1 month | +8.78% | ||
| 3 months | +35.88% | ||
| 6 months | +73.51% | ||
| Current year | +41.29% |
1 week
69.85
80.20
1 month
69.8581.95
Current year
45.1081.95
1 year
43.70100.70
3 years
43.70490.00
5 years
43.70490.00
10 years
43.70490.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jiezhang Hu
CEO | Chief Executive Officer | 50 | 20-12-20 |
Lily Li Dong
DFI | Director of Finance/CFO | 54 | 21-05-19 |
Xin Song
COO | Chief Operating Officer | 36 | 11-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dai Feng
CHM | Chairman | 48 | 18-11-28 |
Xiao Jing Han
BRD | Director/Board Member | 69 | 21-04-30 |
Hao Zhou
BRD | Director/Board Member | 47 | 23-04-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 2 M€ | -14.14% | ||
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 79.9 | +5.13% | 455 600 |
| 24-04-25 | 76 | -1.68% | 228,000 |
| 24-04-24 | 77.3 | +4.11% | 418,670 |
| 24-04-23 | 74.25 | +1.99% | 451,600 |
| 24-04-22 | 72.8 | -1.09% | 545,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 03:54 am EDT
More quotes
ANGELALIGN TECHNOLOGY Inc is a clear aligner dental treatment solution provider. The Company provides dental professionals with self-developed digital orthodontics solutions. The Companyâs Angelalign clear aligner system facilitate dental professionals throughout the entire clear aligner treatment process, include digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, help dental professionals design, review and modify treatment plans; customized, removable clear aligners based on specific treatment plans, is a removable, transparent, plastic form of dental braces used to treat malocclusion; and cloud-based service platform, iOrtho, helps to placing orders, reviewing, modifying and finalizing their treatment plans online with the help from its medical designers, and reviewing, editing and managing medical records of their patients.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
76
HKD
Average target price
84.13
HKD
Spread / Average Target
+10.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +41.29% | 1.64B | |
| -7.51% | 16.43B | |
| +7.40% | 13.63B | |
| +8.24% | 9.89B | |
| -19.87% | 2B | |
| +10.75% | 1.79B | |
| +13.02% | 600M | |
| 0.00% | 475M | |
| +26.44% | 134M | |
| +21.80% | 86.89M |
- Stock Market
- Equities
- 6699 Stock
